Takara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc. from February 16 to April 6, 2026, and purchased all 31,733,101 shares tendered.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4974","jir_company_name":"Takara Bio Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-07","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4974-20260407-01.pdf","jir_short_summary":"Takara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc. from February 16 to April 6, 2026, and purchased all 31,733,101 shares tendered.","jir_summary":"### Overview of the Tender Offer\nTakara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc. from February 16 to April 6, 2026. The purchase price was 1,150 JPY per share. The number of shares tendered reached 31,733,101, and Takara Holdings purchased all tendered shares. After the purchase, Takara Holdings' voting rights ownership ratio became 87.27%.\n\n### Future Outlook and Delisting Schedule\nFollowing the results of the tender offer, Takara Bio Inc.'s common shares are scheduled to be delisted from the Tokyo Stock Exchange Prime Market after completing the required procedures. Once delisted, trading of the shares will no longer be possible. Subsequently, the company is expected to transition to a structure in which only the tender offeror is a shareholder via squeeze-out procedures. Details will be promptly disclosed once finalized.","jir_financial_highlights":"Scheduled Purchase Quantity: 47,065,467 shares (Unknown)\nLower Limit of Scheduled Purchase Quantity: 6,927,000 shares (Unknown)\nNumber of Tendered Shares (Converted to Shares): 31,733,101 shares (Unknown)\nPurchase Price: 1,150 JPY\/share (Unknown)\nTender Offeror's Voting Rights Ownership Ratio After Purchase: 87.27% (Unknown)","jir_category":"","jir_hashtags":"#TakaraBio, #TenderOffer, #TOB, #JapaneseStocks","jir_key_figures":"Scheduled Purchase Quantity: 47,065,467 shares\nNumber of Tendered Shares: 31,733,101 shares\nPurchase Price: 1,150 JPY\/share\nVoting Rights Ownership Ratio After Purchase: 87.27%\nTender Offer Period: 2026-02-16 to 2026-04-06","jir_meta_title":"Tender Offer Result by Takara Holdings for Takara Bio Inc. and Scheduled Delisting (April 2026)","jir_meta_description":"Takara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc., purchasing 31,733,101 shares at a price of 1,150 JPY per share. The voting rights ownership ratio after purchase is 87.27%, and delisting is scheduled.","jir_og_title":"Tender Offer Result by Takara HD for Takara Bio and Future Outlook","jir_og_description":"Takara Holdings has completed the tender offer for Takara Bio shares, acquiring a voting rights ownership ratio of 87.27%. Procedures toward delisting are underway.","jir_og_image_url":"\/assets\/og\/company-tender_offer.jpg","jir_chart_data_collection":"[]","ir_related_company":9678,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-39332","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n